In late 2023 the FDA placed a group of peptides, including CJC-1295 and Ipamorelin, into a restricted category, and that classification has been in transition through 2025 and 2026 as the agency reconsiders how these substances are handled
After a year being off the medication only people who lost 15% or more of their body weight still retained meaningful weight loss. Its not just weight
BPC-157s unique stability allows it to remain intact in human gastric juice for over 24 hours, distinguishing it from typical peptides that rapidly degrade
until it was eventually banned by the FDA in December 2003 due to its risk of cardiovascular adverse effects (AEs).6 This case illustrates the risk associated with the current situation in the U.S., where medications extracted from plants might not be allowed to be marketed as medications
Preliminary results have been encouraging, but long-term success remains unknown
What Potential Does GHK-Cu Hold in Anti-Aging Research